SMOX Inhibition Preserved Visual Acuity, Contrast Sensitivity, and Retinal Function and Reduced Neuro-Glial Injury in Mice During Prolonged Diabetes
Moaddey Alfarhan, Fang Liu, Bayan R. Matani, Payaningal R. Somanath, S. Priya Narayanan · 2024
Read SMOX Inhibition Preserved Visual Acuity, Contrast Sensitivity, and Retinal Function and Reduced Neuro-Glial Injury in Mice During Prolonged Diabetes by Moaddey Alfarhan, Fang Liu, Bayan R. Matani, Payaningal R. Somanath, S. Priya Narayanan (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11674681.txt.
Description
Vision loss from diabetes may be slowed by blocking one enzyme, and a 2024 mouse study by Moaddey Alfarhan and co-authors tests that idea. The enzyme, called SMOX, helps control a family of cell chemicals, and an earlier study found that blocking it cut nerve damage after twelve weeks of diabetes.
The team gave diabetic mice the blocking drug MDL 72527 and tracked them for 24 weeks. Treated mice kept sharper vision, better contrast sense, and healthier inner retina function than untreated diabetic mice. Markers tied to nerve and support cells in the retina also stayed closer to normal. The findings support longer study of the drug as a way to protect sight.
Catalog record
| CREATOR | Moaddey Alfarhan, Fang Liu, Bayan R. Matani, Payaningal R. Somanath, S. Priya Narayanan |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |